ArticleFrontiers in immunology2023

Transarterial chemoembolization combined donafenib with/without PD-1 for unresectable HCC in a multicenter retrospective study.

Hao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.